Avet Pharmaceuticals

4 recalls Categories: Prescription Drugs

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level

Mar 26, 2020 Prescription Drugs Nationwide View Details →

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level

Mar 26, 2020 Prescription Drugs Nationwide View Details →